Page 36 - சூரியன் மருந்து தொழில்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com s offering. The actinic keratosis treatment market is anticipated to showcase a considerable growth rate during the forecast period. The rising prevalence and incidence of actinic keratosis treatment along with the rising development of novel approaches for the treatment of actinic keratosis is anticipated to be a key factor contributing to the growth of the market. The actinic keratosis treatment market is segmented based on type, and end-user. Based on the type, the market is segmented into medication, therapy, and other (combination therapy). Medication to showcase considerable growth based on treatment type. The growing FDA approval for the new drugs to treat actinic keratosis is anticipated to drive the growth of this market segment. Based on medication, the market is segmented into fluorouracil, imiquimod, ingenol mebutate, others. Based on therapy, the market is segmented into photodynamic therapy and LASER surg

United statesUnited kingdomIngenol mebutateLaura woodSun pharmaceutical industries ltdCompany share analysisTeva pharmaceutical industries ltdKey company analysisBausch health companies incOffice hours callAlma lasers incResearch methodologyResearch methodsCompany profilesBiolinerx ltdGlobal actinic keratosis treatment market research